These authors share last authorship.
A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation
Version of Record online: 2 OCT 2012
Copyright © 2012 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
EMBO Molecular Medicine
Volume 4, Issue 11, pages 1186–1199, November 2012
How to Cite
Goldmann, T., Overlack, N., Möller, F., Belakhov, V., van Wyk, M., Baasov, T., Wolfrum, U. and Nagel-Wolfrum, K. (2012), A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation. EMBO Mol Med, 4: 1186–1199. doi: 10.1002/emmm.201201438
- Issue online: 2 NOV 2012
- Version of Record online: 2 OCT 2012
- Manuscript Accepted: 22 AUG 2012
- Manuscript Revised: 17 AUG 2012
- Manuscript Received: 11 APR 2012
- Funded Access
Total views by type:
Publication date: 2 Oct 2012. Cumulative views from 2 Oct 2012 - 1 Jun 2016.
- Total views: 2424
- Total PDF views: 745
- Total HTML views: 1679
- * Although we update our data on a daily basis (not in real time), there may be a 48-hour delay before the most recent numbers are available.
About this data
Usage data should be viewed in relation to:
- the publication date (older articles will generally have higher usage).
- the relevance of the article to a broad community (some articles will be extremely important but to smaller sections of the research community), and
- the availability and usage of the article through other sources
Article usage data is not a precise measure of an individual article's importance and should only be considered alongside other measures of visibility/importance.